The MEDRAD Stellant CT Injection System provides saline flush capabilities and protocol options.

The DualFlow upgrade enables simultaneous injection of contrast and saline while the XDS detects the start of an extravasation by directly sensing contrast media pooling under the skin and automatically stopping injection until a clinician can examine the patient.

The Spectris Solaris EP MR Injection System, also featured at RSNA, promises enhanced power management performance through longer battery life and an Integrated Continuous Battery Charger (iCBC) option.

For current and emerging needs in the MR environment, the newest MR injector from the MEDRAD is compatible with all magnet strengths up to 3.0T, according to its manufacturer.
The MEDRAD Avanta is an advanced fluid management system that is reportedly flexible enough for multiple cardiac imaging applications.

It is intended to inject contrast in variable mode at low flow rates and low pressures for coronary and small vessels, fixed mode at high flow rates and high-pressure injections for larger vessels and peripherals and fixed mode for saline flushing.


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now